Stem cell
-
DATABASE (68)
-
ARTICLES (55)
Possibly Europe's most famous e-commerce investor, Rocket Internet is known for replicating the business models of successes like Amazon, Alibaba and Uber in new markets. Rocket is based in Berlin and was founded in 2007 by brothers Oliver, Alexander and Marc Samwer. It went public in 2014.
Possibly Europe's most famous e-commerce investor, Rocket Internet is known for replicating the business models of successes like Amazon, Alibaba and Uber in new markets. Rocket is based in Berlin and was founded in 2007 by brothers Oliver, Alexander and Marc Samwer. It went public in 2014.
The VC arm of one of Japan's largest internet and media companies, CyberAgent Ventures specializes in the Internet-related industry. It invests in startups at various stages from the seed stage. CyberAgent has 10 offices in 8 countries mainly in Asia, including Jakarta, Beijing, Shanghai and Shenzhen.
The VC arm of one of Japan's largest internet and media companies, CyberAgent Ventures specializes in the Internet-related industry. It invests in startups at various stages from the seed stage. CyberAgent has 10 offices in 8 countries mainly in Asia, including Jakarta, Beijing, Shanghai and Shenzhen.
Steve Christian is the co-founder of Indonesian entertainment website KapanLagi.com. Launched in 2003 with a five-member team, KapanLagi.com has grown to an over 500-employee company and merged with Fimela Network in 2014 to create the Kapan Lagi Network (KLN). KLN has a monthly readership of 40 million.
Steve Christian is the co-founder of Indonesian entertainment website KapanLagi.com. Launched in 2003 with a five-member team, KapanLagi.com has grown to an over 500-employee company and merged with Fimela Network in 2014 to create the Kapan Lagi Network (KLN). KLN has a monthly readership of 40 million.
Lever VC was founded in 2018 by Nick Cooney, an early investor of Beyond Meat and Memphis Meats. He is also the co-founder of Good Food Institute. Lever has currently invested in 14 startups from the US, Europe, Asia and Latin America.Focused on investments in early-stage alternative protein companies, the firm announced the first close of its Lever VC Fund I in August 2020, with its fourth close at $46m in April 2021. The final close will be completed by June 2021. Investors in the fund include NFL and NBA athletes, British nobility, food businesses, alt-protein companies and family offices as limited partners.In June 2020, Lever launched a $28m joint investment fund and accelerator to invest in Chinese plant-based and cell-cultivated meat and dairy companies. The Lever China Alternative Protein Fund will invest RMB 40m in alt-protein companies in mainland China over the next four years.
Lever VC was founded in 2018 by Nick Cooney, an early investor of Beyond Meat and Memphis Meats. He is also the co-founder of Good Food Institute. Lever has currently invested in 14 startups from the US, Europe, Asia and Latin America.Focused on investments in early-stage alternative protein companies, the firm announced the first close of its Lever VC Fund I in August 2020, with its fourth close at $46m in April 2021. The final close will be completed by June 2021. Investors in the fund include NFL and NBA athletes, British nobility, food businesses, alt-protein companies and family offices as limited partners.In June 2020, Lever launched a $28m joint investment fund and accelerator to invest in Chinese plant-based and cell-cultivated meat and dairy companies. The Lever China Alternative Protein Fund will invest RMB 40m in alt-protein companies in mainland China over the next four years.
Since 2003, US-based Wavemaker Partners have invested in more than 150 technology startups. The firm usually start with a US$100,000–$750,000 check and can follow on until US$1 million to US$1.25 million. Its investment portfolio in Asia-Pacific includes Luxola and TradeGecko. In 2016, it acquired Ardent Capital’s VC portfolio, which includes Sale Stock and Happyfresh.
Since 2003, US-based Wavemaker Partners have invested in more than 150 technology startups. The firm usually start with a US$100,000–$750,000 check and can follow on until US$1 million to US$1.25 million. Its investment portfolio in Asia-Pacific includes Luxola and TradeGecko. In 2016, it acquired Ardent Capital’s VC portfolio, which includes Sale Stock and Happyfresh.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Architect and co-founder of QingCloud
Co-founder and Architect of QingCloud. A top scorer in the National College Entrance Examination of Hainan province, Lin received his bachelor’s and master’s degrees at Tsinghua University and later worked for IBM and Tencent. Lin Yuan is now in charge of the API level technology at QingCloud.
Co-founder and Architect of QingCloud. A top scorer in the National College Entrance Examination of Hainan province, Lin received his bachelor’s and master’s degrees at Tsinghua University and later worked for IBM and Tencent. Lin Yuan is now in charge of the API level technology at QingCloud.
CEO and Founder of DataHunter
Founder and CEO of DataHunter. Cheng graduated from Southeast University in 2001. An entrepreneur since 2005, he founded two other startups before DataHunter. With 17 years of experience in the IT industry and in enterprise services, he now works in data visualization.
Founder and CEO of DataHunter. Cheng graduated from Southeast University in 2001. An entrepreneur since 2005, he founded two other startups before DataHunter. With 17 years of experience in the IT industry and in enterprise services, he now works in data visualization.
Co-founder and CEO of Halal Local
Muhammad Senoyodha Brennaf has been building businesses since his time as a computer science and information engineering undergraduate at Inha University, South Korea. Between 2010 and 2014, he sold SIM cards and cellphones to foreigners, while being engaged in an export-import business. In 2015, Senoyodha pursued a master's in Advanced Computer Science at Manchester University, UK before returning to Indonesia a year later to establish Astrajingga, the app development startup behind travel listing platform Halal Local.
Muhammad Senoyodha Brennaf has been building businesses since his time as a computer science and information engineering undergraduate at Inha University, South Korea. Between 2010 and 2014, he sold SIM cards and cellphones to foreigners, while being engaged in an export-import business. In 2015, Senoyodha pursued a master's in Advanced Computer Science at Manchester University, UK before returning to Indonesia a year later to establish Astrajingga, the app development startup behind travel listing platform Halal Local.
CTO and co-founder of iLoF
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
PT Juvisk Tri Swarna (JTS) was established in 2013 to provide technical project management, financial consultancy, site audits and other support services in diverse business sectors; ranging from infrastructure, civil engineering, construction and mineral mining. Juvisk is currently involved in the construction of radio and cellular towers and other related services. In 2016, Juvisk became an investor and business partner of Qlue.
PT Juvisk Tri Swarna (JTS) was established in 2013 to provide technical project management, financial consultancy, site audits and other support services in diverse business sectors; ranging from infrastructure, civil engineering, construction and mineral mining. Juvisk is currently involved in the construction of radio and cellular towers and other related services. In 2016, Juvisk became an investor and business partner of Qlue.
Founded in 2008, KIZOO Technology Ventures is a seed and early-stage VC. Current CEO Michael Greve, who founded Flug.de and Web.de, has many years of experience in the German-speaking Internet industry. KIZOO generally focuses on SaaS, Internet and mobile startups, although it has recently ventured into rejuvenation biotech, investing in companies such as CellAge and LysoClear.
Founded in 2008, KIZOO Technology Ventures is a seed and early-stage VC. Current CEO Michael Greve, who founded Flug.de and Web.de, has many years of experience in the German-speaking Internet industry. KIZOO generally focuses on SaaS, Internet and mobile startups, although it has recently ventured into rejuvenation biotech, investing in companies such as CellAge and LysoClear.
The VC arm of Tsinghua University, THG Ventures was founded in 2015. It is managed by the investment team from the state-owned Tsinghua Holdings Ltd., which has specialized in venture capital investments since 1999 and is one of the first China teams focused on RMB investment. The team also founded TusPark Incubator and TusPark Ventures.
The VC arm of Tsinghua University, THG Ventures was founded in 2015. It is managed by the investment team from the state-owned Tsinghua Holdings Ltd., which has specialized in venture capital investments since 1999 and is one of the first China teams focused on RMB investment. The team also founded TusPark Incubator and TusPark Ventures.
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
Future Food Asia 2021: Long road ahead for the clean meat industry
Crucial basic research is still needed to ensure the safety, quality, and production efficiency of lab-grown meat. Concerted public and private sector efforts will accelerate progress
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Cocuus: Industrial-scale solutions to design and print food
This Spanish startup is pioneering industrial-scale 3D food printing using inkjet and laser technology that prints up to 30 times faster with eye-catching food designs
In Spain, DIY drones help entice students to study science and tech
Spanish startup Bonadrone aims to revolutionize the way science, math and technology are taught in schools and is disrupting the drone sector by enabling users to customize their own 3D-printed drones
Chinese DIY robotics startup Makeblock enters the classroom
Present in more than 140 countries, this ambitious startup is taking global STEM education by storm
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
China’s startups have much to gain from the US-China trade war
The prolonged trade conflict may be exactly what Chinese startups need to strengthen their technological capabilities
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Sorry, we couldn’t find any matches for “Stem cell”.
